US 2013/0096099 A1 · METHOD OF TREATING BRAIN CANCER

Abstract

A therapeutic method for treating brain cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.

Claims9

Dependent claims

A method of treating or delaying the onset of brain cancer comprising administering to a patient in need of treatment a pharmaceutically acceptable salt of trans-[tetrachlorobis(1H-indazole)ruthenate(III)].

Dependencies are inferred from the claim text.

Facts

Application

13/663,438Filed 29 Oct 2012

Priority

29 Apr 2010

Published

18 Apr 2013

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/555
Heterocyclic compounds: containing heavy metals, e.g. hemin, hematin, melarsoprol
A61K 31/17
Amides, e.g. hydroxamic acids: having the group >N—C—N< or >N—C—N<, e.g. urea, thiourea, carmustine
A61K 31/415
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2-Diazoles
A61K 31/416
1,2-Diazoles: condensed with carbocyclic ring systems, e.g. indazole

Abstract

A therapeutic method for treating brain cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.

Method of treating brain cancer

Life of this patent

Abstract

Claims9

Method of treating brain cancer

Life of this patent

Abstract

Claims9